Bryan, Garnier & Co announces record revenues as investment in sustainability continues to gather pace

London, 23 February 2022 – Bryan, Garnier & Co, the leading independent investment bank for European healthcare and technology-led companies has announced record revenues in the firm’s 2021 Activity Report, Investment Banking for a Better Future. ( 

The report also highlights that 85% of the €2.75bn of capital raised for clients in 2021 was for companies that are actively working to improve human health and to help the fight against climate change. The firm completed over 70 transactions for companies and investors, many of which are focused on solving some of the most important challenges facing the world today across healthcare, sustainability and the energy transition. The firm completed 35 M&A transactions with leading private equity investors and global corporations and acted as bookrunner for more than 35 growth financings, from later stage private placements to IPOs and follow-ons, on six different European stock markets and on the US Nasdaq. 

Olivier Garnier, Managing Partner of Bryan Garnier said:

“We are thrilled to share this report marking what has been a fantastic year for the firm. Since founding the firm 25 years ago, our purpose has been to provide capital and strategic solutions to companies and investors that are disrupting the status quo and have a positive impact on our health, how we live, how we consume and the world around us. Investment banking for a better future continues to be our mission and the sectors that we serve are experiencing unparalleled traction and making more of an impact than ever before.

In addition to celebrating 25 years of service to our clients, 2021 was an important year in the firm’s history having led more sector-defining transactions and larger deals inside and outside Europe.” 

Greg Revenu, Managing Partner of Bryan Garnier said:

“The firm has continued to showcase how we approach investment banking with meaning and purpose and continue to fulfil our mission of investment banking for a better future. It is what motivates us as bankers and what makes Bryan Garnier a unique place to work. 

Enabling the success of some of the most innovative companies in Europe and their investors is core to our purpose and we thank our clients who continue to choose us as their trusted long-term partner.”

In 2021, Bryan Garnier also welcomed Clifford Siegel to the firm as Chairman. 

Cliff Siegel, Chairman of Bryan Garnier said:

“Despite the obstacles of the ever-shifting Covid landscape, financial markets and investment banks have delivered strong performances, and in the midst of such a buoyant year, Bryan Garnier has continued to distinguish itself as a world-class investment bank. This report is a celebration of the many extraordinary accomplishments across the firm over the last year, underscoring the power and opportunity of our platform for our clients and for our people.” 

Read the full report

About Bryan, Garnier & Co 

Bryan Garnier is the world’s leading independent full-service investment bank for European healthcare and technology-led companies and their investors. Clients benefit from our relentless commitment to their long-term success, unparalleled insights into these strategically important 

sectors and strong relationships with investors – from private equity and venture capital to institutional investors across the US, Europe, and Asia. 

Our corporate clients operate in high growth, fast moving sectors and many are disruptors focused on solving some of the most important sustainability challenges facing the world today. As a sector driven investment bank, our advice is rooted in deep industry knowledge with a global perspective, and clients benefit from our full-service platform and product expertise that will accelerate their long-term success.  

We partner with clients for the long term throughout their lifecycle, providing them with ideas, access to public and private capital and M&A advisory with flawless execution. Our highly experienced equity research team thinks beyond the obvious to provide compelling and differentiated insights and investment themes to our corporate and investor clients, giving them that important competitive edge.  

Our independence and entrepreneurial culture, which come from being a 25-year-old partnership ensure complete alignment with our clients. Our purpose, which is to help European pioneers become global champions, has been constant since the bank’s foundation 25 years ago and remains why clients continue to choose Bryan Garnier as their partner for the long term. 


Media Contacts  

Desiree Maghoo, Questor Consulting


Sophie Mills, Questor Consulting


Green hydrogen

Find out more about how green hydrogen is helping to fight climate change and reduce environmental degradation.


Bryan Garnier & Co, registered in France no. 452 605 512 is a MiFID branch of Bryan Garnier & Co Limited (a UK company registered under the number 03034095) and is authorized and regulated by the Financial Conduct  Authority and the Autorité des Marchés Financiers (AMF). Registered address: 26 avenue des Champs Elysées, Paris 75008.

This has been prepared solely for informational purposes, and is intended only for use by the designated recipient(s). This information was obtained from sources we believe to be reliable, but its accuracy is not guaranteed. All information is subject to change without notice. This does not constitute a solicitation or offer to buy or sell securities or any other instruments, or a recommendation with respect to any security or instrument mentioned herein. This is not a confirmation of terms of any transaction. No representations are made herein with respect to availability, pricing, or performance. Additional information available on request.
This recording should only be listened to by those persons to whom it is addressed and is not intended to be relied upon by any person without subsequent written confirmation of its contents. If you have received this information in error, please destroy it and delete it from your computer. Any form of reproduction, dissemination, copying, disclosure, modification, distribution and/or publication of this recording is strictly prohibited. Please note that any views or opinions presented in this podcast are solely those of the participants and do not necessarily represent those of Bryan, Garnier & Co. Finally, the recipient should check this source and any attachments for the presence of viruses. Bryan, Garnier & Co accepts no liability for any damage caused by any virus transmitted by this communication.